Oct 10, 2024
News & partners
Dianosic is a biotech focused on the development of novel solutions integrated drug and
delivery system for the localized treatment of patients with chronic rhinitis and chronic rhinosinusitis.
Latest news
Feb 12, 2024
Dianosic shortlisted for the “Trophées des Entreprises Alsace 2024” award
See more
Feb 12, 2024
Dianosic x France Deeptech
See more
Sep 08, 2023
Dianosic plans to raise EUR 10m in Series A; to seek exit sale around 2026
See more
Jul 10, 2023
Major Funding Milestone: Dianosic raises 4.7M€ – February 2023
See more
Jul 10, 2023
Dianosic laureate of the i-Lab 2019 innovation contest
See moreThey support us
Our investors
We built a solid network of partners to support company funding and growth.
Wiseed
Bpi France
Fondation Force
Eurométropole de Strasbourg
Banque Populaire Rives de Paris
Caisse d’épargne Grand Est
